Ahco.O
AHCO.O operates as a health care provider and services entity, generating revenue through its disclosed business activities within the health care sector.
Business. AHCO.O operates as a health care provider and services entity, generating revenue through its disclosed business activities within the health care sector.
Analyst recommendations
8 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressKevin Hern — AdaptHealth Corp.2023-04-06 · Republican · OK · Sale · $1,001 - $15,000
- CongressSusie Lee — AdaptHealth Corp.2022-11-30 · Democrat · NV · Sale · $1,001 - $15,000
- CongressKevin Hern — AdaptHealth Corp.2022-04-22 · Republican · OK · Sale · $1,001 - $15,000
- CongressKevin Hern — AdaptHealth Corp.2022-04-01 · Republican · OK · Sale · $50,001 - $100,000
- CongressKevin Hern — AdaptHealth Corp.2021-08-25 · Republican · OK · Purchase · $100,001 - $250,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
AHCO.O operates as a health care provider and services entity, generating revenue through its disclosed business activities within the health care sector.
AHCO.O maintains a capital structure characterized by significant leverage, with long-term debt of $1.72 billion against total equity of $1.52 billion, resulting in a debt-to-equity ratio of 1.13. The company reports a market capitalization of $1.46 billion and trades at a price-to-book ratio of 0.96, indicating valuation near tangible book value. Liquidity is assessed as medium risk, with a key flag noting that net cash is negative after subtracting total debt, despite operating cash flow of $602 million.
Profitability metrics reflect current operational challenges, with a net income loss of $70.8 million and an operating income of $90.9 million on revenue of $3.24 billion. Return on equity stands at -4.66% and return on assets at -1.64%, signaling inefficient capital deployment relative to the asset base of $4.32 billion. The enterprise value to EBITDA multiple is 34.98, suggesting high valuation relative to earnings power, while EV to revenue is 0.98.
Segment and geographic revenue concentration data is not available in the provided input, preventing detailed analysis of revenue mix or regional exposure. The company’s total assets of $4.32 billion and liabilities of $2.79 billion indicate a substantial balance sheet presence, but without segment breakdowns, the specific drivers of the $3.24 billion revenue stream remain opaque.
Historical growth trajectory data is absent from the input, limiting the ability to assess revenue trends or net income progression over time. The current financial snapshot shows capital expenditures of $382 million, which is substantial relative to operating cash flow, potentially impacting free cash flow generation.
Risk assessment highlights medium liquidity risk and low dilution risk, with the primary concern being the negative net cash position after debt subtraction. The company has 135.45 million shares outstanding, with no difference between basic and diluted shares, indicating no immediate dilutive securities in the current period.
Recent observations include analyst estimates with a mean price target of $13.19 and a median of $13.50, reflecting a positive sentiment relative to the current market price of $10.80. The mean recommendation is 2.00, with two strong buys, four buys, and two holds, suggesting institutional confidence in future performance. News events indicate system reconciler activities but no specific corporate actions or disclosures.
- AHCO.O trades at a price-to-book ratio of 0.96, near tangible book value, with a market cap of $1.46 billion.
- The company reports a net loss of $70.8 million and negative returns on equity (-4.66%) and assets (-1.64%).
- High leverage is evident with a debt-to-equity ratio of 1.13 and long-term debt of $1.72 billion.
- Analyst sentiment is positive, with a mean price target of $13.19 and a mean recommendation of 2.00.
- Liquidity risk is medium due to negative net cash after debt, despite $602 million in operating cash flow.
- Dilution risk is low, with no difference between basic and diluted shares outstanding.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,83 |
| Revenue | —no estimate | —no estimate | 3,5B USD |
| Operating income | —no estimate | —no estimate | 257,1M USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Chief Technology Officer · Employee Stock Option (right to buy) → Common StockDisposed 89 451 @ $4,38exercise · 2026-03-13
Actions
Ask Handelsavisen
- Reference data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Market Capmarket_price * shares_outstanding_diluted
- AdaptHealth Corp. Market data — financials · 2026-08-02
- reconciler_enqueue (reconciler) on AHCO.O · 2026-08-02
- Adapthealth Corp Market data — analyst estimates · 2026-08-02
- AHCO.O HA canonical relationships · 2026-08-02
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,02 %$33M
- Investment Managers · as of 2026-03-310,02 %$82M
- Investment Managers · as of 2026-03-310,01 %$10M
- Investment Managers · as of 2026-03-310,01 %$12M
- Institutional Investor · as of 2026-03-310,01 %$96M
- Institutional Investor · as of 2026-03-310,00 %$19M
- Investment Managers · as of 2026-03-310,00 %$25M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2024-06-300,00 %$136M
- Funds · as of 2026-03-310,00 %$20M
- Investment Managers · as of 2026-03-310,00 %$32M
- Investment Managers · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$13M
- Investment Managers · as of 2026-03-310,00 %$51M
- Investment Managers · as of 2025-12-310,00 %$117M
- Investment Managers · as of 2026-03-310,00 %$3M
- Institutional Investor · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2024-12-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
- Chief Commercial Officer · Common StockSold 11 275 @ $10,44$118K · 2026-07-01
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 18 999 · 2026-06-24
- Director · Common StockOther 6 070 @ $9,89$60K · 2026-06-24
- Chief Commercial Officer · Common StockSold 11 275 @ $10,06$113K · 2026-06-01
- Chief Operating Officer · Common StockOther 20 134 · 2026-05-27
- 10% owner · Common StockBought 447 100 @ $9,91$4,4M · 2026-03-20
- 10% owner · Common StockBought 727 @ $9,94$7K · 2026-03-19
- Chief Technology Officer · Common StockOther 89 451 @ $4,38$392K · 2026-03-13
- Chief Technology Officer · Common StockOther 58 203 @ $10,33$601K · 2026-03-13
- 10% owner · Common StockBought 689 336 @ $9,73$6,7M · 2026-03-12
- 10% owner · Common StockBought 536 827 @ $9,73$5,2M · 2026-03-11
- 10% owner · Common StockBought 820 528 @ $9,73$8,0M · 2026-03-10
- Director · Common StockOther 73 472 · 2026-03-05
- Director · Common StockBought 8 000 @ $8,96$72K · 2026-02-27
- CLO and General Counsel · Common StockBought 5 000 @ $8,91$45K · 2026-02-26
- Chief Operating Officer · Common StockOther 68 330 · 2026-01-30
- CLO and General Counsel · Common StockOther 53 688 · 2026-01-30
- Chief Commercial Officer · Common StockOther 48 807 · 2026-01-30